Use code ONLINE20 to get 20% off global market reports and stay up to date on tariff changes, macroeconomic trends and global economic changes.
What is the expected CAGR for periodontal disease treatment market by 2025?
Significant expansion has been seen in the market for periodontal disease treatments in recent times. Forecasts show its value will grow from a baseline of $1.56 billion in 2024 to $1.67 billion in 2025, reflecting a steady compound annual growth rate of 7.0% over that time frame. This upward trajectory over the past period is largely credited to several converging factors, including a growing elderly demographic, improvements in dental care facilities, a higher prevalence of chronic and aggressive forms of periodontitis, an increased overall susceptibility to gum disease, and a growing patient population suffering from periodontitis.
What is the forecast size of the global periodontal disease treatment market by 2029?
In terms of Driver 1, the market comprising periodontal disease treatments is projected to experience robust expansion in the coming years, reaching a valuation of $2.19 billion by the year 2029, reflecting a steady compound annual growth rate (CAGR) of 6.9%. This upward trajectory throughout the forecast period is fueled by several key factors, notably the increased need for superior oral hygiene, increasing incidence of complete tooth loss (gingivitis), greater frequency in performing periodontal therapeutic interventions, escalating spending on promotional activities, and expanding medical and dental tourism. At the same time, important developments expected in the coming years include technological advancements, incorporation of new technologies, development of sophisticated periodontal treatment methods, incorporation of artificial intelligence for diagnostic purposes, and advances in advanced periodontal flap surgical techniques.
See the full report here:
https://www.thebusinessresearchcompany.com/report/periodontal-disease-treatment-global-market-report
Top Growth Factors in Periodontal Disease Treatment Industry: What is Accelerating the Market?
The escalating occurrence of oral health-related ailments is expected to boost the expansion of the periodontal disease treatment market in the future, as these disorders, which include issues such as tooth decay, gum disease, oral infections, and oral cancers, are on the rise due to factors such as inadequate dental habit, poor hygiene, alcohol consumption. demographic aging and deficiencies in access to adequate dental services. Treatments for periodontal disease serve to control and prevent these oral health problems by mitigating gum inflammation, infection, and subsequent loss of bone structure. For example, data from the Australian Institute of Health and Welfare (AIHW), a government body in Australia, showed that in 2022, poor oral health, mainly tooth decay, gum disease and missing teeth, affected a significant proportion of both Australian children and adults, accounting for 4.5% of the total non-disease health burden. issues will be a catalyst for the expansion of the market dedicated to the management of periodontal disease.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21253&type=smp
What trends will shape the periodontal disease treatment market by 2029 and beyond?
Leading entities in the field of periodontal disease treatment are focusing their efforts on pioneering innovative therapeutic approaches, exemplified by dental gels designed to promote bone regeneration, expand patient access to care, reduce the need for surgery, and provide superior, more enjoyable substitutes for established periodontal procedures. Oral medicinal preparations incorporating antibacterial, anti-inflammatory or fluoride compounds are categorized as dental gels, serving the purpose of preventing tooth decay, relieving gum disease and soothing oral pain. For example, in October 2024, the American biotechnology company Oral Biolife Inc. presented Ambrilux Dental Gel, a new treatment specially designed to stimulate bone regeneration in cases of periodontal disease, evidence from important animal studies showing highly encouraging results. Following successful trials conducted on Beagle dogs, where every individual receiving the treatment showed measurable bone growth, this technological advance has the potential to fundamentally transform minimally invasive dental procedures for both humans and their pets, targeting a significant gap that exists in medical treatment options today.
What are the main segments in the periodontal disease treatment market?
The periodontal disease treatment market covered in this report is segmented into –
1) By Type: Gingivitis. Chronic Periodontal Disease? Aggressive Periodontal Disease? Other species
2) By type of treatment: Non-surgical treatment. Scaling And Root Planning? Medicine; Surgical Treatment? Flap surgery? Bone grafts? Other types of treatment
3) By Route of Administration: Oral. Injectable
4) By Distribution Channel: Hospital Pharmacies. Retail pharmacies? Other distribution channels
5) By End User: Hospitals. Clinic; Dental office? Dental Academic and Research Institutes. Other End Users
Subsections:
1) From Gingivitis: Gingivitis caused by plaque. Gingivitis not caused by plaque
2) From chronic periodontal disease: Mild periodontitis. Mild periodontitis? Severe periodontitis
3) With aggressive periodontal disease: localized aggressive periodontitis. Generalized Aggressive Periodontitis
4) With other types: Necrotizing Periodontal Disease. Periodontitis associated with systemic diseases
Customize your information and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21253&type=smp
Which leading companies are driving the growth of periodontal disease treatment market?
Major companies operating in the periodontal disease treatment market are Bausch Health Companies Inc., DENTSPLY SIRONA Inc., Straumann AG, Sunstar Suisse SA, NovaBone Products LLC, Nakanishi Inc., Brasseler USA, Geistlich Pharma AG, BIOLASE Inc., Bien-Air Dental, Martinl.H. Schumacher, Yoshida Dental MFG. Co. Ltd., Botiss Biomaterials GmbH, Millennium Dental Technologies Inc., PreXion Inc., AMD Lasers Inc., Steris Healthcare Pvt Ltd, Perio Protect, Deppeler SA.
Which regions will dominate the periodontal disease treatment market by 2029?
North America was the largest region in the periodontal disease treatment market in 2024. Asia Pacific is expected to be the fastest growing region during the forecast period. Regions covered in Periodontal Disease Treatment market report are Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Buy the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21253
This report supports:
1. Business leaders & investors – To identify growth opportunities, assess risks and guide strategic decisions.
2. Manufacturers & Suppliers – To understand market trends, customer demand and competitive position.
3. Policy makers and regulators – Monitor industry developments and align regulatory frameworks.
4. Consultants & Analysts – To support market entry, expansion strategies and client consulting work.
Contact us:
Business Research Company: https://www.thebusinessresearchcompany.com/,
America +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow us at:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn more about the Business Research Society
With more than 17500+ reports from 27 industries spanning 60+ geographies, The Business Research Company has built a reputation for providing comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research and unique insights from industry leaders, you can get the insights you need to stay ahead.
This version was published on openPR.
